Insiders Talphera, Inc.

Equities

TLPH

US00444T2096

Delayed Nasdaq Other stock markets 01:15:29 2024-05-17 pm EDT			5-day change	1st Jan Change
1.115 ^USD	-3.04%		+9.85%	+51.70%

May. 14	Transcript : Talphera, Inc., Q1 2024 Earnings Call, May 14, 2024
May. 14	Talphera, Inc. Appoints Dr. Shakil Aslam as Chief Development Officer, Effective May 20, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Talphera, Inc. Appoints Dr. Shakil Aslam as Chief Development Officer, Effective May 20, 2024	May. 14	CI
Talphera, Inc. Announces Management Changes	Mar. 01	CI
Talphera, Inc. Appoints Abhinav Jain to Serve as a Class II Director	Jan. 22	CI
AcelRx Pharmaceuticals, Inc. has Changed its Name to Talphera, Inc	Jan. 09	CI
AcelRx Pharmaceuticals, Inc. Announces Resignation of Mark G. Edwards as Board of Director	22-03-01	CI
AcelRx Pharmaceuticals, Inc. Appoints Jill Broadfoot to Board of Directors	21-11-23	CI
AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors	21-03-31	CI
AcelRx Pharmaceuticals, Inc. Announces Board Changes	20-04-08	CI
Acelrx Pharmaceuticals, Inc. Announces Resignation of John Saia as General Counsel	19-01-11	CI
AcelRx Pharmaceuticals, Inc. Appoints John Saia as General Counsel, Effective April 16, 2018	18-03-27	CI
AcelRx Pharmaceuticals, Inc. Appoints Raffi M. Asadorian as Chief Financial Officer, Effective August 16, 2017	17-07-19	CI
Acelrx Pharmaceuticals, Inc. Announces Executive Changes	17-06-05	CI
AcelRx Pharmaceuticals, Inc. Announces Management Changes	17-02-16	CI
AcelRx Pharmaceuticals, Inc. Announces DSUVIA as Brand Name for ARX-04 in the United States	17-01-09	CI
AcelRx Pharmaceuticals, Inc. Appoints Howard B. Rosen as Chief Executive Officer, Effective April 1, 2016	16-03-29	CI
AcelRx Pharmaceuticals, Inc. Appoints Gina Ford as Vice President Commercial Strategy	15-10-01	CI
AcelRx Pharmaceuticals, Inc. Appoints Howard B. Rosen as Interim Chief Executive Officer, Effective April 1, 2015	15-03-20	CI
AcelRx Pharmaceuticals, Inc. Announces the Departure of Richard King as CEO and President	14-11-05	CI
AcelRx Pharmaceuticals, Inc. Announces Executive Changes	14-06-02	CI
AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer	14-03-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Talphera, Inc.

Equities

TLPH

US00444T2096

Insiders

Filters